Dominick Latremouille-Viau, MSc

Manager
Analysis Group, Canada

Poster(s):

• (385) Real-world treatment history and economic outcomes of CD38 antibody-based regimens in relapsed/refractory multiple myeloma in the United States
  Wednesday, October 29, 2025